Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Geriatric Communication Skills Training Program for Oncology Clinicians

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03530969
Recruitment Status : Active, not recruiting
First Posted : May 21, 2018
Last Update Posted : March 17, 2021
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to learn more about the effects of a training program designed to help doctors communicate better with older patients and their caregivers.

Condition or disease Intervention/treatment Phase
GI Cancer Lymphoma GU Cancer Bone Marrow Transplant Behavioral: Self-Efficacy Assessment Behavioral: UCLA Geriatrics Attitudes Scale Behavioral: Course Evaluations Behavioral: The Consultation and Relational Empathy (CARE) questionnaire Behavioral: Consumer Assessment of Health Care Providers and Systems Program (CAHPS) Behavioral: Patient activation measure (PAM) scale Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 88 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Geriatric Communication Skills Training Program for Oncology Clinicians to Improve Management of Care for Geriatrics Cancer Patients
Actual Study Start Date : May 7, 2018
Estimated Primary Completion Date : May 2022
Estimated Study Completion Date : May 2022

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: GI/GU/Lymphoma Oncologists
Doctors specializing in treating gastrointestinal cancer (cancer of the stomach, pancreas, colon, etc.), genitourinary cancer (cancer of the genitals and urinary tract), and lymphoma (cancer affecting the blood and lymph nodes)
 Behavioral: Self-Efficacy Assessment
Health Care Professional's self-efficacy will be assessed by 12 ratings of self-reported confidence from (1) "strongly disagree" to (5) "strongly agree" in module-specific topics both before and after the training.

Behavioral: UCLA Geriatrics Attitudes Scale
The UCLA Geriatrics Attitudes Scale is a 14-item scale developed to assess health care providers' attitudes toward older persons and caring for older patients.
Other Name: Perceived Ageism

Behavioral: Course Evaluations
The evaluation surveys for each of the three modules will contain fifteen statements assessing post-training attitudes regarding the skills learned and application of skills in oncology clinical practice, measured on a 5-point Likert scale.
Active Comparator: Participants with GI/GU/Lymphoma Cancer
Patients of the physicians in group 1
 Behavioral: The Consultation and Relational Empathy (CARE) questionnaire
The Consultation and Relational Empathy (CARE) questionnaire is a 10-item self-report scale that measures a patient's satisfaction with how empathic their health care providers (HCP) was within a specific consultation.
Other Name: Perceived Empathy

Behavioral: Consumer Assessment of Health Care Providers and Systems Program (CAHPS)
Patients" perceptions of the quality of their interactions with their clinicians will be rated with 6 items from the Consumer Assessment of Health Care Providers and Systems Program (CAHPS)
Other Name: Satisfaction with communication

Behavioral: Patient activation measure (PAM) scale
The PAM scale contains 22 items that assess patient engagement in their care process.
Other Name: Patient Activation.
Active Comparator: Caregivers of Participants with GI/GU/Lymphoma Cancer
Family members or caregivers of the patients in group 2
 Behavioral: The Consultation and Relational Empathy (CARE) questionnaire
The Consultation and Relational Empathy (CARE) questionnaire is a 10-item self-report scale that measures a patient's satisfaction with how empathic their health care providers (HCP) was within a specific consultation.
Other Name: Perceived Empathy

Behavioral: Consumer Assessment of Health Care Providers and Systems Program (CAHPS)
Patients" perceptions of the quality of their interactions with their clinicians will be rated with 6 items from the Consumer Assessment of Health Care Providers and Systems Program (CAHPS)
Other Name: Satisfaction with communication


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Feasibility of Health Care Provider (HCP) training [ Time Frame: 8 weeks ]
    Measured by number of HCP successfully recruited for the training

  2. Participants satisfaction with Health Care Provider (HCP) training [ Time Frame: 1 week ]
    Self-reported measure of satisfaction


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Clinician Eligibility

  • MSK medical oncology Health Care Professionals (HCP) - specifically identified as Attendings, fellows, or Advance Practice Professional (APP) - either a Nurse Practitioner (NP) or Physician Assistant (PA) from GI, GU Oncology, Lymphoma, Bone Marrow Transplant or Geriatrics Service (five services with a large number of geriatric patients)
  • Willingness to be audio-recorded as per self-report
  • Clinician has individual clinic consultations with patients in the target population: 65 years of age and over, English speaking, and patients who have had a new visit within the last 6 months.

Patient Eligibility

  • MSK patients 65 years of age and over as per EMR
  • English speaking as per EMR
  • Being seen by one of the consented HCPs as per the HCP and/or electronic medical record (EMR)
  • Willingness to be audio-recorded as per self-report
  • Patient had their first visit with the clinician within the last 6 months

Caregiver Eligibility

  • English speaking as per EMR
  • Accompanying an MSK patient being seen by one of the consented HCPs as per the HCP and/or EMR

Exclusion Criteria:

  • N/A
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03530969


Locations
Layout table for location information
United States, New York
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Investigators
Layout table for investigator information
Principal Investigator: Smita Banerjee, PhD Memorial Sloan Kettering Cancer Center
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT03530969    
Other Study ID Numbers: 18-183
First Posted: May 21, 2018    Key Record Dates
Last Update Posted: March 17, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No